DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy

Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read More

Top Stories

Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...
AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to

Today, we're witnessing an unprecedented convergence of...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical Affairs

This whitepaper explores the role of social media in enhancing Medical Affairs functions. As digital...

Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight

We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...

Maximizing Efficiency and Compliance with Expert Compendia and Monograph Review Services

Cactus Life Sciences specializes in compendia reviews, providing invaluable assistance to pharmaceutical companies. Our expert...
Medical Review

Uncovering the Benefits of Medical Review: A Comprehensive Overview

Medical review promises scientific data accuracy and has paramount importance at all the stages of...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Stakeholder perspectives on digital scientific content

Digital Scientific Content: Stakeholder Perspectives

What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...

Learn more ABOUT our company.